Envestnet Asset Management Inc Eagle Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$44.58 - $52.6 $355,347 - $419,274	-7,971 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$45.82 - $56.9 $40,779 - $50,641	-890 Reduced 10.04%	7,971 $406,000
Q3 2021 Oct 07, 2021	BUY	$43.79 - $55.78 $20,230 - $25,770	462 Added 5.5%	8,861 $494,000
Q2 2021 Aug 04, 2021	SELL	$36.86 - $44.5 $52,156 - $62,967	-1,415 Reduced 14.42%	8,399 $359,000
Q1 2021 May 04, 2021	BUY	$40.32 - $50.97 $5,725 - $7,237	142 Added 1.47%	9,814 $410,000
Q4 2020 Feb 02, 2021	SELL	$41.72 - $51.34 $31,748 - $39,069	-761 Reduced 7.29%	9,672 $450,000
Q3 2020 Oct 09, 2020	SELL	$37.02 - $51.28 $8,440 - $11,691	-228 Reduced 2.14%	10,433 $443,000
Q2 2020 Jul 08, 2020	SELL	$43.24 - $55.02 $11,501 - $14,635	-266 Reduced 2.43%	10,661 $512,000
Q1 2020 Apr 23, 2020	BUY	$34.37 - $60.07 $16,119 - $28,172	469 Added 4.48%	10,927 $503,000
Q4 2019 Feb 11, 2020	SELL	$54.32 - $64.31 $36,340 - $43,023	-669 Reduced 6.01%	10,458 $628,000
Q3 2019 Oct 17, 2019	BUY	$53.25 - $59.98 $69,225 - $77,974	1,300 Added 13.23%	11,127 $629,000
Q2 2019 Aug 02, 2019	BUY	$46.61 - $58.45 $93,965 - $117,835	2,016 Added 25.81%	9,827 $547,000
Q1 2019 May 10, 2019	BUY	$38.66 - $51.82 $55,322 - $74,154	1,431 Added 22.43%	7,811 $394,000
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $234,273 - $432,117	6,380 New	6,380 $257,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.